Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Dec 2019 | Dec 2020 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 58,950 | 7,059 | 63,649 | 29,624 | 8.0% | 319.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 58,950 | 7,059 | 63,649 | 29,624 | 8.0% | 319.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 58,950 | 7,059 | 63,649 | 29,624 | 8.0% | 319.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 58,950 | 7,059 | 63,649 | 29,624 | 8.0% | 319.6% | 15.3 | More Info
|
BIOCON | 17,481 | 2,335 | 18,574 | 1,877 | 6.3% | -19.6% | 29.4 | More Info
|
BIOCON | 17,481 | 2,335 | 18,574 | 1,877 | 6.3% | -19.6% | 29.4 | More Info
|
CIPLA | 43,710 | 3,536 | 51,687 | 7,525 | 18.2% | 112.8% | 15.2 | More Info
|
CIPLA | 43,710 | 3,536 | 51,687 | 7,525 | 18.2% | 112.8% | 15.2 | More Info
|
CIPLA | 43,710 | 3,536 | 51,687 | 7,525 | 18.2% | 112.8% | 15.2 | More Info
|
DIVIS LABORATORIES | 13,963 | 3,591 | 17,014 | 4,706 | 21.9% | 31.1% | 53.8 | More Info
|
DIVIS LABORATORIES | 13,963 | 3,591 | 17,014 | 4,706 | 21.9% | 31.1% | 53.8 | More Info
|
GLENMARK PHARMA | 27,356 | 1,908 | 27,868 | 2,482 | 1.9% | 30.0% | N.A. | More Info
|
LUPIN | 37,693 | -8,748 | 40,174 | 4,412 | 6.6% | N.A. | 18.4 | More Info
|
LUPIN | 37,693 | -8,748 | 40,174 | 4,412 | 6.6% | N.A. | 18.4 | More Info
|
LUPIN | 37,693 | -8,748 | 40,174 | 4,412 | 6.6% | N.A. | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 38,057 | 5,983 | 31,686 | 6,520 | -16.7% | 9.0% | N.A. | More Info
|
SUN PHARMA | 81,549 | 10,237 | 88,368 | 19,181 | 8.4% | 87.4% | 13.0 | More Info
|
SUN PHARMA | 81,549 | 10,237 | 88,368 | 19,181 | 8.4% | 87.4% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 36,381 | 3,644 | 36,330 | 4,859 | -0.1% | 33.3% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 36,381 | 3,644 | 36,330 | 4,859 | -0.1% | 33.3% | 11.4 | More Info
|
Sector Aggregate | 844,167 | 60,106 | 910,304 | 224,554 | 7.8% | 273.6% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Sep 2020 Results | Mar 2021 Results | Latest Quarter Results | View All Results |